ZEB1 transcription factor promotes immune escape in melanoma
Background The efficacy of immunotherapies in metastatic melanoma depends on a robust T cell infiltration. Oncogenic alterations of tumor cells have been associated to T cell exclusion. Identifying novel cancer cell-intrinsic non-genetic mechanisms of immune escape, the targeting of which would rein...
Saved in:
| Main Authors: | Christophe Caux, Stephane Dalle, Arnaud de la Fouchardière, Laurie Tonon, Maud Plaschka, Valentin Benboubker, Maxime Grimont, Justine Berthet, Jonathan Lopez, Myrtille Le-Bouar, Brigitte Balme, Garance Tondeur, Lionel Larue, Alain Puisieux, Yenkel Grinberg-Bleyer, Nathalie Bendriss-Vermare, Bertrand Dubois, Julie Caramel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-03-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/10/3/e003484.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ZEB1 transcription factor induces tumor cell PD-L1 expression in melanoma
by: Chloé Wirbel, et al.
Published: (2025-03-01) -
ZEB1‐mediated melanoma cell plasticity enhances resistance to MAPK inhibitors
by: Geoffrey Richard, et al.
Published: (2016-09-01) -
An in vivo avian model of human melanoma to perform rapid and robust preclinical studies
by: Loraine Jarrosson, et al.
Published: (2023-01-01) -
Interleukin-35 impairs human NK cell effector functions and induces their ILC1-like conversion with tissue residency features
by: Valentin Picant, et al.
Published: (2025-07-01) -
Customized Hydrogel System for the Spatiotemporal Sequential Treatment of Periodontitis Propelled by ZEB1
by: Jiafei Chen, et al.
Published: (2025-07-01)